GLENMARK PHARMACEUTICALS LT INR 1.0
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GLENMARK PHARMACEUTICALS LT INR 1.0 COM, CUSIP Y2711C144.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GLENMARK PHARMACEUTICALS LT INR 1.0 COM, CUSIP Y2711C144.